| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATPase plasma membrane Ca2+ transporting 3 | 0.631 | 0.692 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
transient receptor potential cation channel subfamily M member 7 | 0.531 | 0.731 | 5.2E-16 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
thioredoxin reductase 1 | 0.529 | 0.692 | 1.6E-06 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
SUZ12 polycomb repressive complex 2 subunit | 0.529 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
gap junction protein beta 1 | 0.514 | 0.731 | 0.85 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
microRNA 144 | 0.500 | 0.769 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 345 | 0.619 | 0.462 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
microRNA 425 | 0.581 | 0.654 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 497 | 0.539 | 0.808 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
prothymosin alpha | 0.604 | 0.731 | 3.4E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
transcobalamin 2 | 0.578 | 0.615 | 1.0E-06 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
microRNA 760 | 0.674 | 0.385 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
gene amplified in esophageal cancer 1 | 0.769 | 0.077 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | |||||||||
|
programmed cell death 6 interacting protein | 0.663 | 0.500 | 0.71 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
Trichoepithelioma, multiple familial, 2 | 0.601 | 0.692 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 1207 | 0.686 | 0.538 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | |||||||||
|
colon cancer associated transcript 1 | 0.585 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
gap junction protein gamma 1 | 0.722 | 0.385 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
colon adenocarcinoma hypermethylated | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 |